Insulet (PODD) Tops Q1 EPS by 23c

Insulet (NASDAQ: PODD) reported Q1 EPS of $1.02, $0.23 better than the analyst estimate of $0.79. Revenue for the quarter came in at $569 million versus the consensus estimate of $543.22 million.

For earnings history and earnings-related data on Insulet (PODD) click here.

You May Also Be Interested In

• Important Notice to Long-Term Shareholders of Bloom Energy Corporation (NYSE: BE); Cogent Communications Holdings, Inc. (NASDAQ: CCOI); Insulet Corporation (NASDAQ: PODD); and Primoris Services Corpor
• Bending Spoons (BSP) PT Raised to $50 at Benchmark on Inaugural Earnings, Revenue Beat
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c